Visualitza per autor "de Castro Carpeno, Javier"
Ara mostrant els elements 1-5 d 5
-
A Delphi consensus panel about clinical management of early-stage EGFR-mutated non-small cell lung cancer (NSCLC) in Spain: a Delphi consensus panel study
Isla, Dolores; Felip Font, Enriqueta; Garrido, Pilar; Majem Tarruella, Margarita; Trigo, José Manuel; de Castro Carpeno, Javier; Remon, Jordi; Insa, Amelia (Springer, 2023-01) -
Economic burden of locoregional and metastatic relapses in resectable early-stage non-small cell lung cancer in Spain
de Castro Carpeno, Javier; Collado-Borell, Roberto; Martínez Marti, Alexandre; Fernández Díaz, Elena; Insa, Amelia; Escudero-Vilaplana, Vicente (BMC, 2023-02-21) -
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer
Borghaei, Hossein; Gettinger, Scott; Vokes, Everett; Chow, Laura; Burgio, Marco Angelo; de Castro Carpeno, Javier; Felip Font, Enriqueta (American Society of Clinical Oncology, 2021-03-01) -
Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus
Isla, Dolores; de Castro Carpeno, Javier; Garcia‑Campelo, Rosario; Lianes, Pilar; Felip Font, Enriqueta; Garrido, Pilar (Springer, 2020-05) -
Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
Garrido, Pilar; Conde, Esther; de Castro Carpeno, Javier; Gómez‑Román, José Javier; Felip Font, Enriqueta; Pijuan, Lara (Springer, 2020-07)